Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Identification of shared and unique mechanisms of atopic dermatitis and ulcerative colitis by construction and computational analysis of disease maps. Local targets link to admitted publications; unresolved targets remain external evidence.
Inflammatory bowel disease and immune-mediated inflammatory diseases: looking at the less frequent associations
10.1177/17562848221115312 · 2022 · External reference
Socioeconomic burden of immune-mediated inflammatory diseases--focusing on work productivity and disability
10.3899/jrheum.110901 · 2011 · External reference
Risk of developing additional immune-mediated manifestations: a retrospective matched cohort study
10.1007/s12325-019-00964-z · 2019 · External reference
Comorbidities of atopic dermatitis-what does the evidence say?
10.1016/j.jaci.2022.12.002 · 2023 · External reference
Bidirectional relationship between atopic dermatitis and inflammatory bowel disease: a systematic review and meta-analysis
10.1016/j.jaad.2020.05.130 · 2020 · External reference
Ulcerative colitis
2013 · External reference
Update on atopic dermatitis
10.20344/amp.11963 · 2019 · External reference
10.3390/ijms221910661
10.3390/ijms221910661 · External reference
10.1007/s00281-019-00751-6
10.1007/s00281-019-00751-6 · External reference
Atopic dermatitis is associated with the clinical course of inflammatory bowel disease
10.1080/00365521.2023.2209688 · 2023 · External reference
Atopic dermatitis and risk of autoimmune conditions: Population-based cohort study
10.1016/j.jaci.2022.03.030 · 2022 · External reference
Atopic dermatitis is associated with an increased risk for rheumatoid arthritis and inflammatory bowel disease, and a decreased risk for type 1 diabetes
10.1016/j.jaci.2015.06.029 · 2016 · External reference
An association between ulcerative colitis and atopic dermatitis, diseases of impaired superficial barriers
10.1111/j.0022-202x.2004.23462.x · 2004 · External reference
Atopic diseases are associated with development of inflammatory bowel diseases in korea: a nationwide Population-based study
2021 · External reference
Causal association between atopic dermatitis and inflammatory bowel disease: a 2-Sample bidirectional mendelian randomization study
10.1093/ibd/izab329 · 2022 · External reference
Causal association between atopic eczema and inflammatory bowel disease: a two-sample bidirectional mendelian randomization study of the east asian population
10.1111/1346-8138.16642 · 2023 · External reference
Systems Medicine disease maps: community-driven comprehensive representation of disease mechanisms
10.1038/s41540-018-0059-y · 2018 · External reference
10.1093/bib/bby024
10.1093/bib/bby024 · External reference
A guide for developing comprehensive systems biology maps of disease mechanisms: planning, construction and maintenance
10.3389/fbinf.2023.1197310 · 2023 · External reference
10.1093/nar/gkaa840
10.1093/nar/gkaa840 · External reference
Exploration and comparison of molecular mechanisms across diseases using MINERVA net
10.1002/pro.4565 · 2023 · External reference
10.1093/nar/gkm958
10.1093/nar/gkm958 · External reference
10.1093/nar/gkr777
10.1093/nar/gkr777 · External reference
Baricitinib: the first jak inhibitor approved in Europe for the treatment of moderate to severe atopic dermatitis in adult patients
2021 · External reference
Safety of baricitinib for the treatment of atopic dermatitis over a median of 1.6 years and up to 3.9 years of treatment: an updated integrated analysis of eight clinical trials
10.1080/09546634.2022.2161812 · 2023 · External reference
Abrocitinib for the treatment of atopic dermatitis
10.2217/imt-2023-0057 · 2023 · External reference
10.1016/j.phrs.2025.107723
10.1016/j.phrs.2025.107723 · External reference
Epithelial barrier defects in ulcerative colitis: characterization and quantification by electrophysiological imaging
10.1053/gast.2001.29694 · 2001 · External reference
10.1016/j.jaci.2017.04.004
10.1016/j.jaci.2017.04.004 · External reference
10.1016/j.jaci.2020.09.023
10.1016/j.jaci.2020.09.023 · External reference
IL-33 is upregulated in colonocytes of ulcerative colitis
10.1016/j.imlet.2009.11.001 · 2010 · External reference
10.1016/j.chom.2023.12.006
10.1016/j.chom.2023.12.006 · External reference
10.1016/j.jaci.2020.02.026
10.1016/j.jaci.2020.02.026 · External reference
10.1002/path.1245
10.1002/path.1245 · External reference
Increased IL-26 expression promotes t helper type 17- and t helper type 2-Associated cytokine production by keratinocytes in atopic dermatitis
10.1016/j.jid.2019.07.713 · 2020 · External reference
Rapamycin blocks the IL-13-induced deficiency of epidermal barrier related proteins via upregulation of miR-143 in HaCaT keratinocytes
10.7150/ijms.45765 · 2020 · External reference
Defects of filaggrin-like proteins in both lesional and nonlesional atopic skin
10.1016/j.jaci.2012.12.1566 · 2013 · External reference
10.1016/j.clim.2007.11.006
10.1016/j.clim.2007.11.006 · External reference
Effects of epithelial IL-13Rα2 expression in inflammatory bowel disease
10.3389/fimmu.2018.02983 · 2018 · External reference
10.1038/mi.2017.52
10.1038/mi.2017.52 · External reference
10.1053/j.gastro.2005.05.002
10.1053/j.gastro.2005.05.002 · External reference
Pathogenesis of atopic dermatitis: current paradigm
2019 · External reference
Age-specific changes in the molecular phenotype of patients with moderate-to-severe atopic dermatitis
10.1016/j.jaci.2019.01.015 · 2019 · External reference
Aberrant expression of circulating Th17, Th1 and Tc1 cells in patients with active and inactive ulcerative colitis
10.3892/ijmm.2013.1287 · 2013 · External reference
10.1038/ni.2920
10.1038/ni.2920 · External reference
STAT6 deficiency ameliorates severity of oxazolone colitis by decreasing expression of claudin-2 and Th2-inducing cytokines
2013 · External reference
10.1111/j.1442-200x.2009.03019.x
10.1111/j.1442-200x.2009.03019.x · External reference
Chlorophyll a and novel synthetic derivatives alleviate atopic dermatitis by suppressing Th2 cell differentiation via IL-4 receptor modulation
10.1016/j.clim.2023.109852 · 2024 · External reference
Autosomal dominant STAT6 gain of function causes severe atopy associated with lymphoma
10.1007/s10875-023-01530-7 · 2023 · External reference
Persistent secretion of IL-18 in the skin contributes to IgE response in mice
10.1093/intimm/dxg062 · 2003 · External reference
FcepsilonRI engagement of langerhans cell-like dendritic cells and inflammatory dendritic epidermal cell-like dendritic cells induces chemotactic signals and different T-cell phenotypes in vitro
2004 · External reference
10.3390/ijms161226172
10.3390/ijms161226172 · External reference
10.1073/pnas.0602900103
10.1073/pnas.0602900103 · External reference
10.1038/mi.2015.13
10.1038/mi.2015.13 · External reference
Expression of interleukin 18 in intestinal mucosa of patients with inflammatory bowel disease and its implications
2003 · External reference
10.1136/gut.50.6.812
10.1136/gut.50.6.812 · External reference
Alpha-toxin is produced by skin colonizing staphylococcus aureus and induces a t helper type 1 response in atopic dermatitis
10.1111/j.1365-2222.2005.02295.x · 2005 · External reference
A new role for conivaptan in ulcerative colitis in mice: inhibiting differentiation of CD4+T cells into Th1 cells
10.1007/s10620-021-07300-y · 2022 · External reference
Amelioration of experimental autoimmune encephalomyelitis and DSS induced colitis by NTG-A-009 through the inhibition of Th1 and Th17 cells differentiation
10.1038/s41598-018-26088-y · 2018 · External reference
10.1016/j.jaci.2020.02.026
10.1016/j.jaci.2020.02.026 · External reference
10.1038/s41419-019-1540-2
10.1038/s41419-019-1540-2 · External reference
Neuronal branching of sensory neurons is associated with BDNF-positive eosinophils in atopic dermatitis
10.1111/cea.13560 · 2020 · External reference
10.1093/ecco-jcc/jjy215
10.1093/ecco-jcc/jjy215 · External reference
10.1016/j.jaci.2013.10.048
10.1016/j.jaci.2013.10.048 · External reference
10.1152/ajpgi.00280.2022
10.1152/ajpgi.00280.2022 · External reference
10.1084/jem.20130351
10.1084/jem.20130351 · External reference
TSLP elicits IL-33-independent innate lymphoid cell responses to promote skin inflammation
2013 · External reference
The interleukin-13 production by peripheral blood t cells from atopic dermatitis patients does not require CD2 costimulation
10.1159/000073716 · 2003 · External reference
10.1016/s1074-7613(01)00243-6
10.1016/s1074-7613(01)00243-6 · External reference
Impaired tight junctions in atopic dermatitis skin and in a Skin-Equivalent model treated with Interleukin-17
10.1371/journal.pone.0161759 · 2016 · External reference
10.3389/fimmu.2014.00461
10.3389/fimmu.2014.00461 · External reference
The TLR and IL-1 signalling network at a glance
2014 · External reference
10.1074/jbc.270.28.16514
10.1074/jbc.270.28.16514 · External reference
Tofacitinib for the treatment of ulcerative colitis, alopecia universalis, and atopic dermatitis: one drug, three diseases
10.1093/ibd/izaa243 · 2021 · External reference
Atopic dermatitis and ulcerative colitis successfully treated with upadacitinib
2023 · External reference
Baricitinib relieves DSS-induced ulcerative colitis in mice by suppressing the NF-κB and JAK2/STAT3 signalling pathways
10.1007/s10787-023-01396-6 · 2024 · External reference
Abrocitinib, tralokinumab and upadacitinib for treating moderate-to-severe atopic dermatitis
2024 · External reference
The systems biology graphical notation
10.1038/nbt.1558 · 2009 · External reference
MINERVA-a platform for visualization and curation of molecular interaction networks
10.1038/npjsba.2016.20 · 2016 · External reference
10.1093/nar/gkab1028
10.1093/nar/gkab1028 · External reference
10.1093/nar/28.1.27
10.1093/nar/28.1.27 · External reference
Signalling maps in cancer research: construction and data analysis
2018 · External reference
10.1016/s1478-5382(03)02370-9
10.1016/s1478-5382(03)02370-9 · External reference
10.1093/nar/gkae1128
10.1093/nar/gkae1128 · External reference
10.1093/nar/gkad1021
10.1093/nar/gkad1021 · External reference
